Redhill Biopharma
RDHL
#11160
Rank
โ‚ฌ2.27 M
Marketcap
0,26ย โ‚ฌ
Share price
-13.08%
Change (1 day)
-71.59%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -705,09ย โ‚ฌ

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -638,12ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -2.279ย โ‚ฌ a decrease over its 2016 EPS that were of -2.006ย โ‚ฌ.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-705,09ย โ‚ฌ
2017-2.279ย โ‚ฌ13.64%
2016-2.006ย โ‚ฌ9.12%
2015-1.838ย โ‚ฌ68.01%
2014-1.094ย โ‚ฌ-25.93%
2013-1.477ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,81ย โ‚ฌ-100.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
0,91ย โ‚ฌ-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,62ย โ‚ฌ-100.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-100.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
1,11ย โ‚ฌ-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel